Results 151 to 160 of about 186,092 (190)
Some of the next articles are maybe not open access.
Low molecular weight heparin, heparin, and warfarin
Current Opinion in Hematology, 1995Low molecular weight heparin is effective for the prevention and treatment of venous thromboembolism. Low molecular weight heparin has the practical advantage that it does not require anticoagulant monitoring and dose adjustment. The simplified therapy provided by low molecular weight heparin may allow many patients with venous thromboembolism to be ...
openaire +2 more sources
Archives of Internal Medicine, 1993
HEARIN WAS first described in 1916 by McLean 1 who was working in the laboratory of Dr William Howell. McLean was given the assignment to extract thromboplastin from various animal tissues. Ironically, rather than isolating procoagulant thromboplastin, he was successful in extracting an anticoagulant. Following his discovery, heparin was found to be an
openaire +2 more sources
HEARIN WAS first described in 1916 by McLean 1 who was working in the laboratory of Dr William Howell. McLean was given the assignment to extract thromboplastin from various animal tissues. Ironically, rather than isolating procoagulant thromboplastin, he was successful in extracting an anticoagulant. Following his discovery, heparin was found to be an
openaire +2 more sources
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine, 2021Patrick R Lawler +2 more
exaly
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine, 2021Ewan C Goligher +2 more
exaly